Johns Hopkins Proton Therapy Center provides highly targeted cancer treatment

Johns Hopkins Medicine will be back in person this year at the Arab Health conference from Jan. 24–27 in Dubai, United Arab Emirates, bringing an interactive virtual tour of the Johns Hopkins Proton Therapy Center, one of the largest and most advanced proton therapy centers in the United States. Since opening in October 2019, the Proton Therapy Center’s staff has treated more than 500 pediatric and adult patients from the U.S. and around the globe. The virtual tour will be available at two kiosks at the Johns Hopkins Medicine booth in H6.D50 of the exhibition congress in the Dubai World Trade Centre.

Located at Sibley Memorial Hospital (a member of Johns Hopkins Medicine) in Washington, D.C., the Johns Hopkins Proton Therapy Center provides adult and pediatric patients with access to highly targeted cancer treatment that spares nearby healthy tissues and organs, potentially reducing side effects and the risk of recurrence. This is particularly important for children, who may have lasting side effects from traditional cancer treatments.

“Since opening just over two years ago, the Johns Hopkins Proton Therapy Center has treated patients with a number of increasingly complex cases using advanced proton therapy techniques,” says Curtiland Deville Jr., M.D., the center’s medical director. “These include mesothelioma, pancreatic and liver cancers, tumors of the brain and spinal cord, and tumors located near the heart and major blood vessels.”

The 7,432 square meter facility is one of the few in the world with a dedicated pediatric team specializing in the care of young patients with cancer. The team delivers compassionate, patient- and family-centered care in collaboration with partners at Children’s National Hospital and the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center’s Division of Pediatric Oncology.

“I am honored to work with a multidisciplinary team of professionals dedicated to the care and treatment of our patients,” says Akila Viswanathan, M.D., M.P.H., M.Sc., director of Johns Hopkins radiation oncology and molecular radiation sciences. “Our team has experience in physics, molecular radiation sciences, radiation oncology, medical oncology, cancer biology, engineering, quantitative sciences and other specialty areas that sets the Johns Hopkins Proton Therapy Center apart from other centers.”

For more information and to take the virtual tour of the Johns Hopkins Proton Therapy Center, visit the Johns Hopkins Medicine booth in H6.D50 at Arab Health 2022. Johns Hopkins Medicine International leaders will be on-site to answer questions and provide information about Johns Hopkins Medicine’s experience in caring for global patients, as well as about innovative solutions for advancing health and health care around the world.

###

About Johns Hopkins Medicine
Johns Hopkins Medicine is a $9.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. It unites the physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of the Johns Hopkins Health System. Diverse and inclusive, Johns Hopkins educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. Johns Hopkins Medicine has six academic and community hospitals in Maryland, the Washington, D.C., metropolitan region and Florida, including The Johns Hopkins Hospital, which opened in 1889. The organization operates six suburban health care and surgery centers and more than 40 primary and specialty care outpatient sites under Johns Hopkins Community Physicians. Johns Hopkins Medicine extends health care into the community through Johns Hopkins Home Care Group and Johns Hopkins HealthCare, and around the world through Johns Hopkins Medicine International. For information about the enterprise and its research, education and clinical programs, and for the latest health, science and research news, visit hopkinsmedicine.org.

About Johns Hopkins Medicine International
Johns Hopkins Medicine International is the division of Johns Hopkins Medicine that is responsible for global advancement of the mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and care. Johns Hopkins Medicine International develops high impact collaborations throughout the world by leveraging Johns Hopkins’ extensive knowledge of medicine, nursing, public health, medical education, research and health care administration to improve health and health care delivery. Johns Hopkins Medicine International also facilitates personalized, culturally appropriate care for Johns Hopkins Medicine’s global patients, and provides specialized concierge health care services.